ARCHIVES

Satraplatin Improved PFS In Refractory Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery

June 30, 2006

Budesonide Not Beneficial For Diarrhea In Melanoma

August 28, 2009

RFPs Available, NIH Funding Strategies

February 18, 1994

NCI Programs: Unequal Outcomes For Minorities The Result of Unequal Treatment NCI Suggests Awareness Campaign

December 17, 1999

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007

In Brief: Bertino Moves To MSK As Head Of Chemotherapy Research; Rosemary Clive Laves ACOS For Elm

January 2, 1987